Envestnet Asset Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20M Buy
841,221
+289,902
+53% +$5.56M ﹤0.01% 1449
2026
Q1
$9.71M Buy
551,319
+527,498
+2,214% +$10.6M ﹤0.01% 1848
2025
Q4
$470K Buy
23,821
+1,295
+6% +$23.3K ﹤0.01% 3747
2025
Q3
$393K Sell
22,526
-441
-2% -$6.54K ﹤0.01% 3914
2025
Q2
$322K Buy
+22,967
New +$370K ﹤0.01% 3981
2022
Q1
Sell
-17,842
Closed -$251K 3929
2021
Q4
$251K Buy
+17,842
New +$312K ﹤0.01% 3516

Other funds holding ALHC

Envestnet Asset Management's ALHC Position: Q2 2026 in Review

Envestnet Asset Management increased its Alignment Healthcare (ALHC) stake by 53% in Q2 2026, buying an estimated $5.56M and bringing the position to 841,221 shares worth $20M. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

Envestnet Asset Management first reported a position in ALHC in Q4 2021 and has held it in 6 quarters since. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Envestnet Asset Management held 841,221 shares of Alignment Healthcare worth $20M as of Q2 2026.
  • Envestnet Asset Management bought 289,902 Alignment Healthcare shares in Q2 2026, an estimated $5.56M.
  • Alignment Healthcare made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1449 holding.
  • Envestnet Asset Management first reported a position in Alignment Healthcare in Q4 2021 and has held it in 6 quarters since.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.